Vanguard Group Inc Kempharm, Inc Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KMPH
# of Institutions
94Shares Held
13.8MCall Options Held
68.1KPut Options Held
42K-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$12.1 Million0.78% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$11.8 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.01MShares$4.99 Million0.05% of portfolio
-
683 Capital Management, LLC New York, NY800KShares$3.95 Million0.34% of portfolio
-
Geode Capital Management, LLC Boston, MA787KShares$3.89 Million0.0% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...